School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Axogen, Inc. AXGN

Healthcare · Medical Devices

$36.13last close 2026-10-09 · market cap $2.12B · delayed data

Trailing returns

1M-23.57%
3M-17.17%
6M+9.42%
1Y+120.04%
5Y+152.83%

Basis: Adjusted daily closes.

What it does

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide.

Open AXGN in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies